Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin in reconstructive pelvic surgery
NCT02999724Phase 3Unknown
- Sponsor
- Mount Sinai Hospital
- Start
- Jan 2017
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Gabapentin with Placebo (2 arms). Primary endpoint: Total Opioid Consumption Post-operation at 24 hours. Status: unknown.
02
Drugs
gabapentin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02999724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02999724.